Delivery Order SPE2DB20D1100-SPE2DB24FB0L6
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Uroxatral 10 mg tablets. The $11,916.73 award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Uroxatral 10 mg tablets. The $38,841.36 firm-fixed-price delivery order has a period of performance ending on September 8, 2023. The award is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the company to supply a wide...
- This federal contract award is for the delivery of Uroxatral 10 mg tablets in quantities of 100 to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $12,658.40 and an ultimate completion date of December 28, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $92,295.85, is for the delivery of Uroxatral 10 mg tablets. It is a firm fixed-price delivery order contract with an ultimate completion date of October 17, 2022. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4559576181 - UROXATRAL 10 MG TABLET 100S. The firm-fixed-price contract has a ceiling value of $2,599.00 and a completion date of January 12, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $46,355.89, is for the delivery of Uroxatral 10 mg tablets. It is a firm fixed-price delivery order with a completion date of September 15, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract, valued at $19,508.56, is for the delivery of 10 mg Uroxatral tablets to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, which serves as the primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,558,157,684 units of Uroxatral 10 mg Tablets in quantities of 100 per bottle. The award, valued at $72,282.72, has a firm fixed price and an ultimate completion date of August 22, 2022. The contract is not designated as a set-aside. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $15,152.40 firm-fixed-price contract is for the delivery of 4,564,829,060 units of the medication Uroxatral (alfuzosin hydrochloride) 10 mg tablets. The order has a completion date of June 7, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 tablets of Uroxatral 10 mg, a medication used to treat enlarged prostate. The fixed-price contract has a ceiling value of $10,098.36 and a performance period ending on June 29, 2023. The contract was not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FB0L6Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of Uroxatral 10 mg tablets. The award has a ceiling value of $9,596.91 and a performance period through April 2, 2024. The contract is a firm fixed price delivery order, and no set-aside designation was used. AmerisourceBergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) awarded by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.6k | 4/1/24 |